tetano
Editor, Senior Moderator
Sci Rep. 2017 Dec 19;7(1):17855. doi: 10.1038/s41598-017-18140-0.
[h=1]Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.[/h] Vassilieva EV[SUP]1[/SUP], Wang S[SUP]1[/SUP], Li S[SUP]2[/SUP], Prausnitz MR[SUP]2[/SUP], Compans RW[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Recent studies indicated that in elderly individuals, statin therapy is associated with a reduced response to influenza vaccination. The present study was designed to determine effects on the immune response to influenza vaccination induced by statin administration in a mouse model, and investigate potential approaches to improve the outcome of vaccination on the background of statin therapy. We fed middle aged BALB/c mice a high fat "western" diet (WD) alone or supplemented with atorvastatin (AT) for 14 weeks, and control mice were fed with the regular rodent diet. Mice were immunized with a single dose of subunit A/Brisbane/59/07 (H1N1) vaccine, either systemically or with dissolving microneedle patches (MNPs). We observed that a greater age-dependent decline in the hemagglutinin inhibition titers occurred in systemically-immunized mice than in MNP- immunized mice. AT dampened the antibody response in the animals vaccinated by either route of vaccine delivery. However, the MNP-vaccinated AT-treated animals had ~20 times higher total antibody levels to the influenza vaccine than the systemically vaccinated group one month postvaccination. We propose that microneedle vaccination against influenza provides an approach to ameliorate the immunosuppressive effect of statin therapy observed with systemic immunization.
PMID: 29259264 DOI: 10.1038/s41598-017-18140-0
Free full text
[h=1]Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.[/h] Vassilieva EV[SUP]1[/SUP], Wang S[SUP]1[/SUP], Li S[SUP]2[/SUP], Prausnitz MR[SUP]2[/SUP], Compans RW[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Recent studies indicated that in elderly individuals, statin therapy is associated with a reduced response to influenza vaccination. The present study was designed to determine effects on the immune response to influenza vaccination induced by statin administration in a mouse model, and investigate potential approaches to improve the outcome of vaccination on the background of statin therapy. We fed middle aged BALB/c mice a high fat "western" diet (WD) alone or supplemented with atorvastatin (AT) for 14 weeks, and control mice were fed with the regular rodent diet. Mice were immunized with a single dose of subunit A/Brisbane/59/07 (H1N1) vaccine, either systemically or with dissolving microneedle patches (MNPs). We observed that a greater age-dependent decline in the hemagglutinin inhibition titers occurred in systemically-immunized mice than in MNP- immunized mice. AT dampened the antibody response in the animals vaccinated by either route of vaccine delivery. However, the MNP-vaccinated AT-treated animals had ~20 times higher total antibody levels to the influenza vaccine than the systemically vaccinated group one month postvaccination. We propose that microneedle vaccination against influenza provides an approach to ameliorate the immunosuppressive effect of statin therapy observed with systemic immunization.
PMID: 29259264 DOI: 10.1038/s41598-017-18140-0
Free full text